PLYMOUTH, Minn. & WASHINGTON--(BUSINESS WIRE)--Lumen Biomedical, Inc., a Minnesota-based medical device company, announced today that Principal Investigator Subbarao V. Myla, M.D. presented the results from the EPIC Clinical Trial: Evaluating the Use of the FiberNet® Embolic Protection System in Carotid Artery Stenting, during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, in Washington DC. The presentation was held Thursday, October 16, 2008 as part of “The Late Breaking First Report Investigations” in the Main Arena.
